Device will not carry concentric collapse contraindication or warning language ...

Fact checked by Jennifer Klump Meet the Author Smita Patel, DO is an integrative neurologist and is affiliated with Endeavor ...

The FDA has approved the proximal hypoglossal nerve stimulation device (aura6000 system) developed by LivaNova for adults ...

Apnimed, Inc., a pharmaceutical company developing an oral drug product candidate, AD109, that is designed to address a root cause of obstructive sleep apnea (OSA), today announced that Shionogi & Co.

Fact checked by Jennifer Klump Meet the Author Christopher Lee, MD, is a board-certified cardiologist and internal medicine ...

--Eli Lilly and Company announced detailed results from the SURMOUNT-OSA phase 3 clinical trials evaluating tirzepatide injection for the treatment of moderate-to-severe obstructive sleep apnea in ...

Snoring is something families joke about; children make inside jokes about the loud sleeper in the house and spouses complain ...

The link between OSA and headaches is well established. “Morning headaches have long been recognized as a marker for sleep apnea,” says Avram Gold, MD, director of the sleep medicine fellowship at the ...

Symptom severity of obstructive sleep apnea (OSA) worsens significantly on the weekends and is likely associated with increased alcohol use and smoking, irregular sleep schedules, and lack of OSA ...

Comorbid insomnia and obstructive sleep apnea are linked to increased long-term risk for cardiovascular and cerebrovascular ...

Please provide your email address to receive an email when new articles are posted on . Adults with obstructive sleep apnea had a greater reduction in events per hour at 1 year with tirzepatide vs.

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...